Shizuru Judith Anne
Jasper Therapeutics, Inc. · Director
Shizuru Judith Anne is listed in filings as Director at Jasper Therapeutics, Inc.. This profile follows SEC Form 4 activity through Sep 24, 2025, including purchase activity. Recent filings connect the profile to Jasper Therapeutics, Inc. (JSPR). The current snapshot covers public activity from Jul 3, 2025 to Sep 24, 2025. Reported amounts are shown as $50.8K to $99.6K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Current Price |
|---|---|---|---|---|
| Historical insider buys and sells before the latest disclosure date will appear here after more snapshots are available. | ||||